Get startedLog in
    Picture of Renalytix logo

    RENX — Renalytix Cashflow Statement

    0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Renalytix, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

    2020
    June 30th
    2021
    June 30th
    2022
    June 30th
    2023
    June 30th
    2024
    June 30th
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-10.6-35.8-49.6-46.2-45.5
    Depreciation
    Amortisation
    Non-Cash Items-0.0335.71.254.8716.4
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-0.6623.360.0166.18-3.21
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-10.1-24.6-45.7-32.7-29.8
    Capital Expenditures-1.31-1.63-0.6940—
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items0.8270.889—00.117
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Other Investing Cash Flow
    Cash from Investing Activities-0.485-0.741-0.69400.117
    Financing Cash Flow Items—0.111-1.51-0.16-0.156
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities16.577.225.515.110.1
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash651.9-23.8-16.7-20